Albert Ferro

6.3k total citations
139 papers, 4.8k citations indexed

About

Albert Ferro is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Albert Ferro has authored 139 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Cardiology and Cardiovascular Medicine, 43 papers in Physiology and 34 papers in Molecular Biology. Recurrent topics in Albert Ferro's work include Nitric Oxide and Endothelin Effects (38 papers), Antiplatelet Therapy and Cardiovascular Diseases (32 papers) and Blood Pressure and Hypertension Studies (15 papers). Albert Ferro is often cited by papers focused on Nitric Oxide and Endothelin Effects (38 papers), Antiplatelet Therapy and Cardiovascular Diseases (32 papers) and Blood Pressure and Hypertension Studies (15 papers). Albert Ferro collaborates with scholars based in United Kingdom, China and United States. Albert Ferro's co-authors include Christopher N. Floyd, Gabriella Passacquale, Yong Ji, James M. Ritter, Haitham H. Al‐Sa'doni, Lindsay Queen, Εugenia Gkaliagkousi, Biao Xu, Pankaj Sharma and Liping Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Albert Ferro

137 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Ferro United Kingdom 39 1.7k 1.3k 1.2k 684 644 139 4.8k
Antonio López‐Farré Spain 39 1.5k 0.9× 1.2k 0.9× 1.5k 1.3× 712 1.0× 355 0.6× 182 5.0k
Akihiro Tojo Japan 45 1.4k 0.8× 1.5k 1.2× 1.6k 1.3× 505 0.7× 617 1.0× 141 5.9k
Uttam Garg United States 27 1.0k 0.6× 1.0k 0.8× 1.7k 1.4× 587 0.9× 434 0.7× 155 4.6k
Catherine Vergely France 42 1.3k 0.8× 2.3k 1.8× 1.5k 1.3× 603 0.9× 722 1.1× 179 7.0k
Nobutaka Inoue Japan 44 1.5k 0.9× 1.5k 1.2× 1.8k 1.5× 832 1.2× 492 0.8× 106 5.5k
Toshiaki Tamaki Japan 41 1.0k 0.6× 1.8k 1.4× 1.2k 1.0× 469 0.7× 352 0.5× 201 5.1k
Jamie Y. Jeremy United Kingdom 40 937 0.6× 826 0.7× 1.2k 1.0× 995 1.5× 609 0.9× 150 4.6k
Neelam Khaper Canada 34 1.2k 0.7× 1.7k 1.3× 761 0.7× 460 0.7× 650 1.0× 86 4.7k
Georg Kojda Germany 32 1.6k 1.0× 1.1k 0.9× 2.1k 1.8× 333 0.5× 481 0.7× 108 4.8k
Daniela Fraccarollo Germany 36 2.0k 1.2× 1.5k 1.2× 1.1k 1.0× 962 1.4× 226 0.4× 96 4.5k

Countries citing papers authored by Albert Ferro

Since Specialization
Citations

This map shows the geographic impact of Albert Ferro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Ferro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Ferro more than expected).

Fields of papers citing papers by Albert Ferro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Ferro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Ferro. The network helps show where Albert Ferro may publish in the future.

Co-authorship network of co-authors of Albert Ferro

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Ferro. A scholar is included among the top collaborators of Albert Ferro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Ferro. Albert Ferro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferro, Albert, et al.. (2024). Predictive risk factors of adverse mental health outcomes in the facial trauma patient. International Journal of Oral and Maxillofacial Surgery. 53(8). 686–694. 1 indexed citations
2.
Gómez‐Ambrosi, Javier, Beatriz Ramírez, Sara Becerril, et al.. (2023). Increased Expression Levels of Netrin-1 in Visceral Adipose Tissue during Obesity Favour Colon Cancer Cell Migration. Cancers. 15(4). 1038–1038. 3 indexed citations
3.
Passacquale, Gabriella, Pankaj Sharma, Divaka Perera, & Albert Ferro. (2022). Antiplatelet therapy in cardiovascular disease: Current status and future directions. British Journal of Clinical Pharmacology. 88(6). 2686–2699. 50 indexed citations
4.
Ferro, Albert. (2016). Mechanistic target of rapamycin modulation: an emerging therapeutic approach in a wide variety of disease processes. British Journal of Clinical Pharmacology. 82(5). 1156–1157. 3 indexed citations
5.
Xie, Liping, Yue Gu, Shuang Zhao, et al.. (2016). Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation. Diabetes. 65(10). 3171–3184. 278 indexed citations
6.
Ferro, Albert, et al.. (2014). Renal denervation as an option for the management of hypertension. Journal of Biomedical Research. 28(1). 18–18. 4 indexed citations
7.
Floyd, Christopher N., et al.. (2014). The PlA1/A2 Polymorphism of Glycoprotein IIIa as a Risk Factor for Myocardial Infarction: A Meta-Analysis. PLoS ONE. 9(7). e101518–e101518. 26 indexed citations
8.
Xie, Jun, Jingjing Wang, Qin Dai, et al.. (2012). Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction. Journal of Molecular and Cellular Cardiology. 53(2). 250–258. 36 indexed citations
9.
Gu, Rong, Jian Bai, Ling Lin, et al.. (2012). Increased Expression of Integrin-Linked Kinase Improves Cardiac Function and Decreases Mortality in Dilated Cardiomyopathy Model of Rats. PLoS ONE. 7(2). e31279–e31279. 31 indexed citations
10.
Han, Yi, Yuan Liu, Qiong‐Yu Mi, et al.. (2010). Pyridoxine Improves Platelet Nitric Oxide Synthase Dysfunction Induced by Advanced Glycation End Products in vitro. International Journal for Vitamin and Nutrition Research. 80(3). 168–177. 5 indexed citations
11.
Gkaliagkousi, Εugenia, Στέλλα Δούμα, Chrysanthos Zamboulis, & Albert Ferro. (2009). Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. Journal of Hypertension. 27(12). 2310–2320. 61 indexed citations
12.
Wu, Yong, Yuan Liu, Yi Han, et al.. (2009). Pyridoxine increases nitric oxide biosynthesis in human platelets. International Journal for Vitamin and Nutrition Research. 79(2). 95–103. 5 indexed citations
13.
Jones, Stuart A., et al.. (2009). Pharmaceutical salts: a formulation trick or a clinical conundrum?. British Journal of Cardiology. 16(6). 281–286. 13 indexed citations
14.
Chen, Lu, Yuan Liu, Bota Cui, et al.. (2007). 17β‐OESTRADIOL PARTIALLY ATTENUATES THE INHIBITION OF NITRIC OXIDE SYNTHASE‐3 BY ADVANCED GLYCATION END‐PRODUCTS IN HUMAN PLATELETS. Clinical and Experimental Pharmacology and Physiology. 34(10). 972–978. 13 indexed citations
15.
Queen, Lindsay & Albert Ferro. (2006). β-Adrenergic receptors and nitric oxide generation in the cardiovascular system. Cellular and Molecular Life Sciences. 63(9). 1070–1083. 38 indexed citations
16.
Ritter, James, et al.. (2006). Nitric oxide regulates the formation of circulating monocyte-platelet aggregates in healthy subjects. British Journal of Clinical Pharmacology. 61(5). 614–614. 1 indexed citations
17.
Queen, Lindsay, et al.. (2006). Age and gender have important effects on platelet nitric oxide production. British Journal of Clinical Pharmacology. 61(5). 612–613. 3 indexed citations
18.
Ferro, Albert, et al.. (2004). The role of the endothelium in the control of vascular function. International Journal of Clinical Practice. 58(2). 173–183. 21 indexed citations
19.
Queen, Lindsay, et al.. (2003). Nitric oxide generation mediated by ?-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus. Diabetologia. 46(11). 1474–1482. 26 indexed citations
20.
Ferro, Albert, Alberto J. Kaumann, & Morris J. Brown. (1995). β-Adrenoceptor Subtypes in Human Coronary Artery. Journal of Cardiovascular Pharmacology. 25(1). 134–141. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio López‐Farré Breakdown of academic impact, for papers by Akihiro Tojo Breakdown of academic impact, for papers by Uttam Garg Breakdown of academic impact, for papers by Catherine Vergely Breakdown of academic impact, for papers by Nobutaka Inoue Breakdown of academic impact, for papers by Toshiaki Tamaki Breakdown of academic impact, for papers by Jamie Y. Jeremy Breakdown of academic impact, for papers by Neelam Khaper Breakdown of academic impact, for papers by Georg Kojda Breakdown of academic impact, for papers by Daniela Fraccarollo
Rankless by CCL
2026